跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS
Authorized
STANDARD
OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS
sanis health inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
bf37f87986bf6a09
Company
sanis health inc
Type
Standard
Approval Details
Approval Id
bf37f87986bf6a09
Drug Approval Canada Name
OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS
Product Name
OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS
Status
Marketed
Status Date
2021-03-16
Original Market Date
2021-03-16
Din
02504294
Drug Class
Human
Dosage Form
Tablet (Delayed-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
56:28.36
Atc Original
A02BC01 OMEPRAZOLE
Atc Name
a 02 bc 01
Aig Number
0121643001
Company Name
sanis health inc
Company Address
1 Presidents Choice Circle, Brampton, Ontario, Canada, L6Y 5S5
Active Ingredients
OMEPRAZOLE (OMEPRAZOLE MAGNESIUM)
20 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
bf37f87986bf6a09
Type
Standard
Back to Health Canada Approvals